Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.66%
1,093.34
-7.23
-0.66%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.14%
604.32
-0.83
-0.14%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.71%
1,215.67
+20.48
+1.71%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.05%
1,721.65
-18.26
-1.05%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.22%
639.94
+1.38
+0.22%
—638.56640.21645.32639.52——
SIXR
Staples
SIXR
Staples
SIXR
+0.58%
836.41
+4.84
+0.58%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.73%
214.92
+1.56
+0.73%
—213.36213.36215.54212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.63%
3,181.55
-52.63
-1.63%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
937.14
+1.49
+0.16%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.01%
1,449.43
+0.17
+0.01%
—1,449.261,454.771,462.651,448.95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.69%
2,365.91
-16.54
-0.69%
—2,382.452,371.192,380.452,364.46——
4543:TYO
Terumo Corp
¥2,055.50
+1.51%
(+30.50) 1D
Apr 28, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4543...
Open
¥2,042
High
¥2,058
Low
¥2,032
Mkt. cap
3.04T
Avg. vol.
5.28M
Volume
3.99M
Dividend
1.36%
Quarterly dividend
¥7
Ex dividend date
Mar 30, 2026
P/E ratio
23.70
52-wk high
¥2,842
52-wk low
¥1,900
EPS
¥87
Shares outstanding
370.59M
No. of employees
31K
News stories
From sources across the web
Profile
Terumo Corporation was founded in 1921 as Red Line Thermometer Corporation by a group of medical scientists led by Dr. Kitasato Shibasaburō to produce medical thermometers in Japan. The company's first product was "Jintan Taionkei", the first Japanese-made thermometer available for sale, and it has since expanded into a medical devices manufacturer, producing medical disposables, cardiovascular systems and diabetes care products. In 1971, Terumo opened its first overseas office in the United States. Since then, the company has established subsidiaries in Europe, South America, China, India, Philippines, Vietnam, Thailand, Australia and México. The company later expanded its product range to include coronary stents and catheters, and acquired, among others, the cardiovascular specialty companies Vascutek and Microvention in 2002 and 2006 respectively. Wikipedia
About Terumo Corp
CEO-
Employees30.7K
FoundedSep 17, 1921
HeadquartersShibuya, Tokyo, Japan
SectorMedical device
Websiteterumo.co.jp
Last report
Feb 13, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-/ -JPY
Revenue / Estimate
296.63B/ (286.14B est.)JPY
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
263.94B
259.96B
274.96B
296.63B
Cost of goods sold
125.40B
114.50B
127.97B
143.44B
Cost of revenue
125.40B
114.50B
127.97B
143.44B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
99.32B
91.98B
97.88B
105.26B
Operating expense
89.11B
89.58B
101.90B
109.31B
Total operating expenses
214.52B
204.08B
229.87B
252.74B
Operating income
49.42B
55.89B
45.10B
43.88B
Other non operating income
75.00M
-2.00M
-1.00M
2.00M
EBT including unusual items
22.74B
55.26B
45.95B
45.38B
EBT excluding unusual items
47.96B
55.26B
45.95B
45.38B
Income tax expense
4.39B
13.42B
10.90B
12.72B
Effective tax rate
19.30%
24.28%
23.72%
28.04%
Other operating expenses
-10.21B
-2.40B
4.02B
4.05B
Net income
18.36B
41.84B
35.05B
32.65B
Net profit margin
6.95%
16.10%
12.75%
11.01%
Earnings per share
-
-
-
-
Interest and investment income
2.70B
873.00M
1.02B
2.21B
Interest expense
-
-1.28B
-18.00M
-463.00M
Net interest expenses
2.70B
-405.00M
1.00B
1.75B
Depreciation and amortization charges
-
-
-
-
EBITDA
70.88B
77.07B
66.76B
69.98B
Gain or loss from assets sale
490.00M
65.00M
4.72B
154.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer